Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 2 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 3 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 4 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 5 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 6 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 7 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 8 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 9 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 10 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 11 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 12 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 13 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 14 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 15 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 16 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 17 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 18 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 19 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 20 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 21 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|
| 22 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL13 1件: IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 1件: 97 💬
|
| 23 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL13 1件: IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 1件: 85 💬
|
| 24 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL13 1件: IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 2件: 85, 97 💬
|